# Ningbo Sansheng Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ningbo-sansheng-biotechnology-co

- Industry: Agribusiness
- Headquarters: Ningbo, China
- Website: www.bio-ss.net
- Latest round: Series B (Nov 15, 2019)
- Investors on record: 1

## About

Founded in 2012 and based in Ningbo, China, Ningbo Sansheng Biotechnology Co., Ltd. operates as a biotechnology company that focuses on the production and sales of veterinary reproductive hormones. It was recognized as the National High-tech Enterprise. The company cooperates with universities such as China Agricultural University, South China Agricultural University, and Huazhong Agricultural University. In August 2020, Ningbo Sansheng Biotechnology Co., Ltd. raised a venture funding for CNY 200 million.

The company is mainly engaged in the production of veterinary reproductive hormones. The products can be divided into two categories: fish and veterinary. The products mainly include allylgestaltenone oral solution, gonadorelin injection, and injection of gonadotropin. The company also promotes batch management technology for sow production and timed insemination technology for large-scale ranches.

The company generates revenue by providing veterinary reproductive hormones.

## Funding rounds

- Series B, Nov 15, 2019 — SDIC Venture Capital

## Investors

- SDIC Venture Capital (https://capitalatlas.ai/funds/sdic-venture-capital) — Series B